Dmitry Grishenkov

I am Associate Professor working at Dept. of Biomedical Engineering and Health Systems, KTH - Royal Institute of Technology.

My Research Group is working with Contrast Enhanced Medical Imaging and Therapy. In particular, experimental and theoretical work concerns characterization of structural and physical properties of multimodal contrast agents developing new and improving existing methods for visualization and quantification of multimodal contrast agents. In collaboration with Karolinska Institute development of novel contrast agent of combined functionality for tissue specific diagnostics and localized drug delivery is carried out. In collaboration with KTH, Department of Applied Physics the first of its kind study on behaviour of microbubble in lab-on chip and organ-on chip set-up is carried out.

I have also experience intechnology transfer, innovation and commercialization.
In 2020 the research results on the water purification from pharmaceutical restudies and PFAS were patented and I have established the spin-off company CaviTreat AB. This work has been acknowledged by The Royal Swedish Academy of Engineering Sciences (IVA) and included in the list of 100 projects that are deemed to offer the greatest potential.

I am Programme Director of the two-year M.Sc. Programme in Innovative Technology for Healthy Living, TIHLM, KTH.

I am also Programme Director of the three-year B.Sc. Programme in Medical Technology, TIMEL, KTH

My reseach lab is located at KTH Campus Flemingsberg (Division of Biomedical Imaging).

Positions associated with the current research:

Associate Professor, Docent in Medical Imaging and Technology (KTH MTH)
Vice director (Vice centrumföreståndare) (KTH Jonassons centrum for medical imaging)